Last week, Chesapeake Energy (NYSE: CHK ) reported a first-quarter profit that beat Wall Street expectations, aided by strong oil production growth and higher natural gas prices during the quarter.
The Oklahoma City-based oil and natural gas producer reported net income of $58 million, or $0.02 a share, compared to a loss of $28 million, or $0.11 a share, in the year-earlier quarter.
Excluding the impact of hedging losses and other one-time items, Chesapeake earned $0.30 a share on revenue of $3.42 billion, topping analyst expectations of a $0.25 per share profit on revenue of $2.85 billion. �
With the company having embarked upon a new strategy of developing its existing asset base ��as opposed to acquiring new assets ��let's take a look at three important takeaways from Chesapeake's first-quarter performance.
Progress in reducing expenses
First up is cost cutting. Eager to lose the stigma of a company that expands recklessly by taking on more and more debt, Chesapeake is now emphasizing capital discipline and seeking to lower operating costs as much as possible.
Top 5 Net Payout Yield Companies To Buy Right Now: Immunomedics Inc.(IMMU)
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe. The company?s products include epratuzumab, a Phase III clinical trail product for the treatment of systemic lupus erythematosus and non-Hodgkin?s lymphoma; Veltuzumab, a Phase I/II clinical study completed product for the treatment of patients with non-Hodgkin?s lymphoma, immune thrombocytopenic purpura, and chronic lymphocytic leukemia; Yttrium Y 90 Clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that is in Phase Ib/II clinical trail; and Yttrium Y 90 epratuzumab tetraxetan, a Phase I/II clinical study product for patients with non-Hodgkin?s lymphoma. Its early phase clinical trial products comprise Milatuzumab, a transmembrane protein product for antibody-drug conjugate therapy. The com pany also develops Dock-and-Lock methodology for making fusion proteins and multifunctional antibodies, as well as a new method of delivering imaging and therapeutic agents selectively to disease, primarily different solid cancers. In addition, it markets and sells a diagnostic product, LeukoScan, which is used to treat infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. Immunomedics, Inc. has a license and collaboration agreement with Nycomed GmbH to develop, manufacture, and commercialize veltuzumab in the subcutaneous formulation for the treatment of various non-cancer indications; and a partnership and cross-licensing agreement with Alexis Biotech Ltd., to develop vaccines against cancers that include melanoma and chronic lymphocytic leukemia, and infectious diseases, such as AIDS. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 stock that's starting to move within range of triggering a big breakout trade is Immunomedics (IMMU), which is focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. This stock is off to a very bullish start in 2013, with shares up sharply by 110%.
If you take a look at the chart for Immunomedics, you'll notice that this stock has been uptrending decent for the last month, with shares moving higher from its low of $4.85 to its recent high of $6.54 a share. During that uptrend, shares of IMMU have been consistently making higher lows and higher highs, which is bullish technical price action. This uptrend is coming after shares of IMMU downtrended during July from $6.91 to that $4.65 a share low. Shares of IMMU are now starting to push within range of triggering a big breakout trade.
Market players should now look for long-biased trades in IMMU if it manages to break out above some near-term overhead resistance at $6.54 a share and then once it clears its 52-week high at $6.91 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 1.15 million shares. If that breakout triggers soon, then IMMU will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $8 to $10 a share, or possibly even north of $10 a share.
Traders can look to buy IMMU off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $5.52 a share or below more support at $5 a share. One can also buy IMMU off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Sean Williams]
In terms of clinical data, small-cap biotechnology company Immunomedics (NASDAQ: IMMU ) jumped by double digits after reporting early stage, but nonetheless positive, data from its antibody-drug conjugate program. Two of Immunomedics' ADC's, IMMU-130 which is targeted at metastatic colorectal cancer, and IMMU-132, which is being tested on 13 different cancer types, demonstrated tumor shrinkage and some partial responses. We're still a long way from an approval, but ADC's certainly look like one pathway to effectively treating cancer. Make sure this is a company you've added to your Watchlist.
- [By Sean Williams]
What: Shares of Immunomedics (NASDAQ: IMMU ) , a biopharmaceutical company researching monoclonal, antibody-based products to treat cancer and other autoimmune disorders, jumped as much as 15% after providing a clinical update on its antibody-drug conjugate programs.
Top 5 Integrated Utility Stocks For 2014: Pinnacle Entertainment Inc.(PNK)
Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.
Advisors' Opinion:- [By Sean Williams]
Time to make the switch
If I could name a sector that I'd certainly tread lightly around considering that consumers are tightening their wallets, it would be the casino sector. Casino companies rely on loose wallets and vacations to drive profits. This is why I feel it could be the time to say goodbye to casino and race track operator Pinnacle Entertainment (NYSE: PNK ) near its 52-week high. - [By Grace L. Williams]
First up is Pinnacle Entertainment (PNK). CEO Anthony Michaal Sanfilippo bought 23,000 shares of the Las Vegas-based gaming company for $505,800. InsiderScore notes this is his first purchase in nearly two years and writes, ��fter shares retreated more than 15% from a six-year high and with an activist hedge fund pushing the casino operator to spin off its real estate into a REIT, Sanfilippo stepped up with his first purchase. [He put] a fresh $500,000 into the stock at a price two times his cost basis of previous buys.��/p>
- [By Dan Radovsky]
Pinnacle Entertainment (NYSE: PNK ) has reached an agreement in principle with the Bureau of Competition of the Federal Trade Commission that would allow the company to complete its proposed acquisition of Ameristar Casinos (NASDAQ: ASCA ) , Pinnacle announced today.
Top 5 Integrated Utility Stocks For 2014: Mostostroy No6 OAO (MSTF)
Mostostroy No6 OAO (Mostostroitel��yi trest No 6 OAO or Bridge Construction Trust N 6 OJSC) is a Russia-based company engaged in the construction industry. Its services portfolio includes the design, construction, reconstruction and renovation of bridges, railways, highways, tunnels and subways, nuclear and thermal power stations, residential and industrial facilities, among others. Mostostroitel��yi trest No 6 OAO provides its services mainly to companies engaged in the transportation, hydraulic engineering, industrial, civil and nuclear construction sectors and its customers include ROSATOM and Russian Railways, among others. The Company operates through 10 branches, as well as two representative offices, located in Moscow and Sochi. In addition, it has five wholly owned subsidiaries. As of March 4, 2011, the Company�� major shareholder was Malakhit OOO with a stake of 19.85%. Advisors' Opinion:- [By Tom Taulli]
But again, the most glaring red flag is the valuation of GOOG stock. Shares of Google stock are currently trading at a P/E ratio of 30, which is certainly rich. Consider that�Apple (AAPL) and �Microsoft (MSTF) sport multiples of only about 14. These companies also have decent dividend yields.
Top 5 Integrated Utility Stocks For 2014: PetroChina Company Limited(PTR)
PetroChina Company Limited produces and distributes oil and gas in the People?s Republic of China. It operates in four segments: Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline. The Exploration and Production segment explores, develops, produces, and markets crude oil and natural gas, oilsands, and coalbed methane. As of December 31, 2010, it had 11,278 million barrels of proved reserves of crude oil; and 65,503 billion cubic feet of proved reserves of natural gas. The Refining and Chemicals segment engages in the refining of crude oil and petroleum products; and production and marketing of petrochemical products, derivative petrochemical products, and other chemical products. This segment?s product line comprises processed crude oil, gasoline, kerosene, diesel, ethylene, synthetic resins, synthetic fiber materials, polymers, synthetic rubber, and urea. The Marketing segment involves in the marketing of refined products and tradi ng businesses. It operated 17,996 service stations. The Natural Gas and Pipeline segment engages in the transmission of natural gas, crude oil, and refined products; and the sale of natural gas. It had a total length of 56,840 kilometers (km) of oil and gas pipelines, including 32,801 km of natural gas pipelines, 14,782 km of crude oil pipelines, and 9,257 km of refined product pipelines. The company was founded in 1988 and is headquartered in Beijing, the People?s Republic of China. PetroChina Company Limited is a subsidiary of China National Petroleum Corporation.
Advisors' Opinion:- [By MARKETWATCH]
HONG KONG (MarketWatch) -- Hong Kong stocks opened higher on Tuesday, as global investors look ahead to U.S. Federal Reserve Chairwoman Janet Yellen's first public remarks later in the day. The Hang Seng Index (HK:HSI) rose 0.7% to 21,722.66. Asia's largest oil and gas company -- PetroChina Co. Ltd (HK:857) (PTR) -- climbed 2%, after the company said it has found a large natural-gas reserve in China's southwestern Sichuan basin, with 308 cubic meters of technically recoverable gas. Cnooc Ltd. (HK:883) (CEO) , China's largest offshore oil and gas producer, jumped 3.3%, while top refiner China Petroleum & Chemical Corp. (HK:386) (SNP) also added 1.6%. Oilfield-equipment shares also benefited from the rally, as China Oilfield Services Ltd. (HK:2883) (CHOLF) gained 1.7%. Huadian Fuxin Energy Corp. Ltd. (HK:816) , the renewable-energy unit of Chinese state-owned power giant China Huadian Corp., jumped 3.2%, after the company said last week it had raised 1.18 billion Hong Kong dollars (about $152 million) through a sale of shares to institutional investors. Waste-management and energy company China Everbright International Ltd. (HK:257) (CHFFF) advanced 2.4%, and China Datang Renewable Power Co. Ltd. (HK:1798) tacked on
- [By Tyler Crowe]
2. Russia: 6041.28 quadrillion BTU
Russia is a giant of natural gas, the national gas company Gazprom and Norway's Statoil (NYSE: STO ) represent 40% of total natural gas imports in Europe, and that is just half of it. Back in March, Gazprom signed a memorandum of understanding (MOU) with PetroChina's (NYSE: PTR ) �state-owned parent company to deliver 1.34 trillion cubic feet per year starting in 2018. The MOU is a long time coming -- the two countries have been working on this deal for more 15 years.
No comments:
Post a Comment